3 hrs ago
Brokerages Cut PB Fintech Targets After Insurance Reform Proposal
PB Fintech owns businesses such as Policybazaar that help people buy insurance.
Its stock dropped sharply after India’s insurance regulator proposed new rules for how insurance can be sold.
The proposal could reduce the commissions that insurance distributors receive.
Some analysts think this could hurt PB Fintech’s earnings, especially in health insurance.
Morgan Stanley said the health business could be affected more than the life-insurance business.
Other analysts said the final rules may change because the current document is only a consultation paper.
Jefferies still recommends buying the stock, but it lowered its price target.
BofA Securities remained neutral, while HSBC downgraded the stock to Hold.
Analysts said investors will likely wait for clearer final regulations.
PB Fintech shares fell over 6% after plunging nearly 36% in the previous session, losing about 40% across two sessions.
The sell-off followed the Insurance Regulatory and Development Authority of India’s proposal for tighter commissions and a ban on certain website dark patterns.
BofA Securities retained Neutral and cut its target to ₹1,410, while Jefferies kept Buy but lowered its target to ₹1,540.
Morgan Stanley estimated PB Fintech’s health-business NPV could fall 60–70%, while life-insurance NPV may remain broadly stable.
HSBC downgraded the stock to Hold with a ₹1,150 target, and Motilal Oswal retained Neutral at ₹1,150 pending final regulations.
- Who
- PB Fintech, its Policybazaar and related businesses, insurance regulators, and brokerages including Jefferies, Morgan Stanley, BofA Securities, HSBC, and Motilal Oswal Financial Services.
- What
- PB Fintech’s shares fell sharply after a proposed insurance-distribution framework prompted brokerages to reduce price targets and revise earnings expectations.
- Where
- The stock traded on the BSE in India; the proposed rules concern insurance distribution in India.
- When
- The sharp decline occurred on 24 September, followed by further trading and broker commentary on 25 September.
- Why
- The proposed rules could tighten commission structures, restrict certain website practices, and reduce the economics of insurance distribution.
More constructive assessments
More cautious assessments
Overall stock outlook
More constructive assessments
Jefferies retained a Buy rating and said the consultation paper could be modified after stakeholder feedback. BofA Securities said Policybazaar could gain market share and that the impact on its life and term insurance business may remain manageable.
More cautious assessments
HSBC downgraded PB Fintech to Hold, while Motilal Oswal retained Neutral and said the stock could remain under pressure until final regulations are announced.
Impact on earnings
More constructive assessments
Jefferies expects management to pursue cost optimisation, and BofA Securities said PB Fintech could protect its core position through capital allocation and market-share gains.
More cautious assessments
Jefferies estimated that a 10% reduction in new-business commission rates could reduce earnings by 10–12%. Motilal Oswal estimated that core online insurance revenue could fall 30% and earnings 46% under its stated scenario before expense reductions or new revenue streams.
Business-line exposure
More constructive assessments
BofA Securities said the impact on Policybazaar’s life and term insurance business could remain manageable, while Morgan Stanley said life-insurance NPV should remain broadly stable. Lower premiums could also support demand growth, according to Morgan Stanley.
More cautious assessments
Morgan Stanley estimated that PB Fintech’s health-business NPV could decline 60–70% and flagged risks to PB Partners POSP’s top line. Jefferies also expects the proposed framework to affect non-life insurance NPV more than life insurance.
Key facts
- Share performance
- PB Fintech shares plunged nearly 36% on 24 September and fell over 6% in the subsequent session, losing about 40% across two sessions.
- Intraday range
- The stock traded between ₹1,131.05 and ₹1,262 on the BSE in the reported session.
- Regulatory proposal
- The Insurance Regulatory and Development Authority of India proposed tighter commission rules and a ban on certain dark patterns on insurance and distributor websites.
- BofA Securities target
- Neutral rating; target reduced to ₹1,410 from ₹1,970.
- Jefferies target
- Buy rating retained; target reduced to ₹1,540 from ₹2,050.
- HSBC target
- Rating downgraded to Hold; target reduced to ₹1,150 from ₹2,100.
- Motilal Oswal view
- Neutral rating retained with a ₹1,150 target; it estimated a potential 30% decline in FY28 core online insurance revenue if the proposal is implemented in its current form.
Sources
Related news
PB Fintech Shares Plunge as Insurance Commission Reforms Spark Fears
PB Fintech Warns of Revenue Hit After IRDAI Proposal
Proposed commission limits threaten PB Fintech’s FY28 earnings
PB Fintech Growth Hinges on Regulatory Clarity and Execution
Irdai Commission Overhaul Pressures PB Fintech and Turtlemint Business Models
Insurance Stocks Slide After IRDAI Proposes Distribution Reforms
Morgan Stanley Accidentally Leaks 100-Plus Deal Pipeline List
Elevate Campuses IPO Opens With Mixed Brokerage Views
NSE IPO Stakes Near ₹30,000 Crore Held by Major Investors
Indian Stocks Shift Lower as Coal India, Meesho Surge
